Justera Addresses Delay on Annual Filings

Rhea-AI Summary

Justera Health (OTC Pink: SCRSF) announces a delay in filing its audited annual financial statements, which may lead to a failure-to-file cease trade order by the OSC. The Company is working to finalize the filings promptly to resume normal trading conditions.

Positive

• None.

Negative

• Delay in filing annual financial statements may lead to a failure-to-file cease trade order, impacting trading of SCRSF shares.

Toronto, Ontario--(Newsfile Corp. - April 29, 2024) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company") regrettably announces that it has not met the deadline for filing its audited annual financial statements, the accompanying management's discussion & analysis for the financial year ended December 31, 2023, and the CEO and CFO certifications (collectively, the "Annual Filings") required under National Instrument 52-109 - Certification of Disclosure in Issuers' Annual and Interim Filings.

Due to this delay in filing the annual filings, the OSC may impose a failure-to-file cease trade order ("FFCTO") against the Company, anticipated to take effect on or after May 1, 2024. If issued, the FFCTO will remain in effect until the required Annual Filings are completed and filed. During this period, trading in the shares of the Company will be halted.

The Company and its auditors are actively working to finalize the annual financial statements and are committed to submitting the Annual Filings as swiftly as possible. The Company is making all efforts to expedite this process and ensure compliance with all regulatory requirements. The company anticipates that the completion of the filings will occur approximately two weeks from the original deadline.

The Company is dedicated to resolving this filing delay promptly and will continue to provide updates to its shareholders and the market as soon as more information becomes available. The Company sincerely appreciates the patience and understanding of its investors during this time and is focused on rectifying the delay to restore normal trading conditions.

About Justera Health

Established in 2020, Justera Health Ltd. is a Canadian company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera's mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.

For additional information on Justera Health and other corporate information, please visit the Company's website at https://www.justerahealth.com/.

For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.com.

Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Investor Relations & Communications

Paul Haber, CFO
Tel: (416) 318-6501
Email: info@justerahealth.com

Forward-Looking Statements:

Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera's business. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera's strategic growth plans, and other factors, many of which are beyond the control of Justera. Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera's expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/207298

FAQ

Why did Justera Health announce a delay in filing its annual financial statements?

Justera Health announced the delay due to not meeting the deadline for filing its audited annual financial statements.

What potential consequence may Justera Health face due to the delay in filing its financial statements?

Justera Health may face a failure-to-file cease trade order by the OSC if the annual filings are not completed in time.

How long does Justera Health anticipate the completion of the filings to take?

Justera Health anticipates that the completion of the filings will occur approximately two weeks from the original deadline.